These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 414118)

  • 1. [Treatment of hypertension with propranolol in internal medicine and general practice. A field trial with a simplified twice daily administration of Dociton 80 (author's transl)].
    Hiemstra S; Ziegler E; Steichele C
    MMW Munch Med Wochenschr; 1977 Dec; 119(49):1599-602. PubMed ID: 414118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative study of acebutolol and propranolol in the treatment of arterial hypertension].
    Tacquet A
    Nouv Presse Med; 1975 Dec; 4(46 Suppl):3294-6. PubMed ID: 768913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of essential hypertension with a combination of propranolol, spironolactone-thiabutazide and dihydralazine (author's transl)].
    Ebel H; Lübke H; Klaus D; Zehner J; Witzgall H
    Dtsch Med Wochenschr; 1978 Oct; 103(42):1650-5. PubMed ID: 699788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of hypertension with tenormin 100 (atenolol). A general practice study (author's transl)].
    Hiemstra S; Ziegler E
    MMW Munch Med Wochenschr; 1980 Dec; 122(49):1777-80. PubMed ID: 6779149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indoramin as second step therapy in the management of benign essential hypertension.
    Montenero AS; Mazzari M; Schiavoni G; Manzoli U; Gherardi S
    Pharmatherapeutica; 1983; 3(6):417-21. PubMed ID: 6353433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled comparison of labetalol and propranolol in the management of severe hypertension.
    Pugsley DJ; Armstrong BK; Nassim MA; Beilin LJ
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):777-82. PubMed ID: 791331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cross-over trial with Peripress (prazosin) and Apresolin (hydralazin), both in combination with beta-blocker].
    Melkild A
    Tidsskr Nor Laegeforen; 1980 Jan; 100(3):148-49. PubMed ID: 6992338
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of arterial hypertension with propranolol (Inderal) in general practice].
    Sederberg-Olsen P; Ronne H; Andersen B
    Ugeskr Laeger; 1976 Nov; 138(47):2953-55. PubMed ID: 790718
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of sotalol and propranolol in mild to moderate essential hypertension.
    Pessina AC; Hlede M; Morandin F; Casiglia E; Gava R; Agnoletto V; Locatelli C; Dal Palu C
    Int J Clin Pharmacol Res; 1983; 3(1):41-5. PubMed ID: 6679506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of labetalol, hydrallazine, and propranolol in the therapy of moderate hypertension.
    West MJ; Wing LM; Mulligan J; Walkley J; Grygiel JJ; Graham JR; Chalmers JP
    Med J Aust; 1980 Mar; 1(5):224-5. PubMed ID: 6990215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-blind comparison of penbutolol and long-acting propranolol in general practice.
    Hayes G
    Pharmatherapeutica; 1983; 3(7):456-63. PubMed ID: 6366804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of clonidine, furosemide and propranolol in the treatment of different phases of hypertension (author's transl)].
    Plaza de los Reyes M; Lazcano F; Orozco R; Osorio I; Passalaqua W; Marzullo E; Campino C; Pla C
    Rev Med Chil; 1977 Aug; 105(8):508-11. PubMed ID: 918430
    [No Abstract]   [Full Text] [Related]  

  • 13. A double-blind crossover clinical trial of labetalol and propranolol in patients of essential hypertension.
    Pandhi P; Aslam S; Sharma BK; Sharma PL; Wahi PL
    Int J Clin Pharmacol Ther Toxicol; 1985 Feb; 23(2):101-4. PubMed ID: 3886563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bopindolol, a new long-acting beta-adrenoceptor antagonist--a randomized comparison against propranolol in hypertensive patients.
    Kirch W; Axthelm T
    Int J Clin Pharmacol Res; 1983; 3(2):89-93. PubMed ID: 6148312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double-blind cross-over clinical trial of acebutolol and propranolol in mild to moderate essential hypertension.
    Pandhi P; Sethi V; Sharma BK; Wahl PL; Sharma PL
    Int J Clin Pharmacol Ther Toxicol; 1985 Nov; 23(11):606-8. PubMed ID: 3908332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ketanserin versus propranolol in the treatment of mild and moderate essential hypertension: corroboration with ambulatory blood pressure monitoring.
    Novo S; Alaimo G; Giordano U; Raineri A; Strano A
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S104-6. PubMed ID: 2446055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crossover comparison of nitrendipine with propranolol in patients with essential hypertension.
    Fritschka E; Distler A; Gotzen R; Thiede HM; Philipp T
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1100-4. PubMed ID: 6085375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of antihypertensive efficacy: propranolol versus oxprenolol in accelerated hypertension.
    Fernandez PG; Sharma JN; Galway AB; Kim BK; Granter S; Zachariah PK
    Pharmatherapeutica; 1982; 3(3):153-6. PubMed ID: 6752962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of hypertension with propranolol in combination with other antihypertensive agents].
    Dück KD
    Z Gesamte Inn Med; 1975 Nov; 30(22):727-30. PubMed ID: 1210474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metoprolol and propranolol in the treatment of essential hypertension - a long-term comparative study.
    Sjöberg KH
    Ann Clin Res; 1981; 13 Suppl 30():23-9. PubMed ID: 7027890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.